Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company’s portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies an... اقرأ أكثر
احصل على تحليلات مفصلة للأسهم من LSEG تتضمن السعر المستهدف بحسب رأي المحللين.